Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026eJHaemOpen Access

Peripheral T‐Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long‐Term Outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBo-Yu HuangLCLi-Chang ChangSHSheng‐Yen Hsiao

Discussion

Loading...

Member takes

Overview

Retrospective cohort study evaluating treatment patterns and survival outcomes in patients with Peripheral T-cell Lymphomas in Southern Taiwan, revealing significant prognostic factors.

Key Points

  • This study aims to characterize the epidemiology, treatment patterns, and survival outcomes of Peripheral T-cell lymphomas in Southern Taiwan over 15 years.
  • Conducted a 15-year retrospective cohort study of 249 patients diagnosed with PTCL in southern Taiwan from 2010 to 2024.
  • Analyzed subtype distribution, treatment patterns, and survival outcomes, including factors affecting prognosis.
  • Median overall survival was 17.6 months and event-free survival was 6.4 months.
  • Identified four independent adverse prognostic factors: ECOG performance status ≥ 2, elevated LDH, >1 extranodal site, and age ≥ 60 years.
  • Salvage chemotherapy followed by HSCT led to prolonged survival after relapse, compared to 6.1 months with salvage chemotherapy alone.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/69fd7f86bfa21ec5bbf08074https://doi.org/10.1002/jha2.70302
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project2024 · 12 citations
  2. 2Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-012012 · 596 citations
  3. 3Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium2024 · 14 citations
  4. 4Survival benefit in patients with peripheral T‐cell lymphomas after treatments with novel therapies and clinical trials2019 · 34 citations
  5. 5Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study2022 · 15 citations